Donaldson Q4 FY26 slides: record $1B+ sales, 17.5% margins

Donaldson (DCI) reported FY2026 Q4 sales of $1.059B (vs $1.04B expected) and adjusted EPS of $1.15 (vs $1.13), with the stock up 2.31% to $95.41. Q4 adjusted operating margin hit 17.5% (+110 bps YoY) and free cash flow conversion reached 136%, while the company paid down $102M of Facet acquisition debt; net leverage rose to 1.4x (from 0.7x) but remains on track to targets. FY2027 guidance calls for sales growth of 5.5%–9.5% to about $4.2B and adjusted EPS of $4.22–$4.38 (~8% vs $3.98), supporting a constructive near-term outlook despite temporary Industrial integration/headwinds.

Analysis

This reads like a higher-quality industrial compounder that is increasingly less about GDP beta and more about mix, pricing power, and self-help. The key second-order effect is that the business is pushing into a profile where recurring aftermarket and regulated applications dominate, which should support a premium multiple versus more hardware-heavy industrial cyclicals even if end markets soften. The combination of strong cash generation and modest leverage also reduces equity downside from the acquisition, while putting pressure on smaller filtration peers and private competitors that lack the same service footprint and balance-sheet flexibility.

The main risk is that the market may be extrapolating temporary mix benefits into a clean margin step-up that is actually back-half dependent. If aerospace/defense supply chain friction persists or power-generation timing slips, the next two quarters could look flatter than the headline trajectory implies, and the stock may de-rate because investors are paying for execution continuity rather than cyclical upside. Falsifiers: no sequential improvement in Industrial margins by the next two reports, or any reset to organic growth assumptions below mid-single digits.

Contrarian view: consensus may be underestimating how much of the recent improvement is already visible in the numbers, while overestimating how much multiple expansion remains. The better trade is not chasing the stock outright, but owning it as a quality industrial relative-value position versus lower-margin, less recurring industrial names. The move is positive, but likely more durable in earnings than in the stock unless the next guide raises the organic growth floor again.

Key Decisions for Investors

• Long DCI on a 2-4% pullback over the next 1-2 weeks; 6-12 month thesis is margin durability plus deleveraging, with downside tied to any guide reset in Industrial.
• Pair trade: long DCI / short XLI for 3-6 months to isolate quality, recurring-margin exposure versus broader industrial cyclicality; cover if PMI-driven industrial breadth improves materially.
• Add DCI only if the next quarter confirms Industrial margin recovery; if not, treat the name as a hold and avoid chasing multiple expansion above current levels.
• Watch DCI credit spreads as a confirmation signal over the next 1-3 months; tighter spreads would validate the deleveraging story, while widening would suggest the market doubts the acquisition integration path.